Björk, Johannes R. http://orcid.org/0000-0001-9768-1946
Bolte, Laura A. http://orcid.org/0000-0001-6036-0831
Maltez Thomas, Andrew http://orcid.org/0000-0001-5789-3354
Lee, Karla A.
Rossi, Niccolo
Wind, Thijs T.
Smit, Lotte M.
Armanini, Federica
Asnicar, Francesco http://orcid.org/0000-0003-3732-1468
Blanco-Miguez, Aitor http://orcid.org/0000-0001-7386-5572
Board, Ruth
Calbet-Llopart, Neus
Derosa, Lisa http://orcid.org/0000-0003-0527-2964
Dhomen, Nathalie http://orcid.org/0000-0003-1961-2173
Brooks, Kelly
Harland, Mark
Harries, Mark
Lorigan, Paul
Manghi, Paolo
Marais, Richard
Newton-Bishop, Julia
Nezi, Luigi http://orcid.org/0000-0002-4670-7656
Pinto, Federica http://orcid.org/0000-0002-4539-4811
Potrony, Miriam
Puig, Susana http://orcid.org/0000-0003-1337-9745
Serra-Bellver, Patricio
Shaw, Heather M.
Tamburini, Sabrina
Valpione, Sara
Waldron, Levi http://orcid.org/0000-0003-2725-0694
Zitvogel, Laurence http://orcid.org/0000-0003-1596-0998
Zolfo, Moreno
de Vries, Elisabeth G. E. http://orcid.org/0000-0002-8949-7425
Nathan, Paul
Fehrmann, Rudolf S. N. http://orcid.org/0000-0002-7516-315X
Spector, Tim D.
Bataille, Véronique
Segata, Nicola
Hospers, Geke A. P. http://orcid.org/0000-0002-3047-7892
Weersma, Rinse K. http://orcid.org/0000-0001-7928-7371
Article History
Received: 20 June 2023
Accepted: 3 January 2024
First Online: 16 February 2024
Competing interests
: R.K.W. acted as a consultant for Takeda; received unrestricted research grants from Takeda, Johnson & Johnson, Tramedico and Ferring; and received speaker fees from MSD, AbbVie and Janssen Pharmaceuticals. E.G.E.d.V. reports an advisory role at Daiichi Sankyo, NSABP and Sanofi (paid to University Medical Center Groningen) and research funding from Amgen, AstraZeneca, Bayer, Chugai Pharma, CytomX Therapeutics, G1 Therapeutics, Genentech, Nordic Nanovector, Radius Health, Regeneron, Roche, Servier and Synthon (paid to University Medical Center Groningen). S.P. received speaker fees from Almirall, BMS, ISDIN, La Roche Posay, Leo Pharma, Regeneron, Roche and Sanofi; acted as advisory board member of Almirall, ISDIN, La Roche Posay, Pfizer, Roche, Regeneron, Sanofi and Sun Pharma; and received research funding from Abbie, AMGEN, ISDIN, La Roche Posay, Leo Pharma and Novartis. R.B. has received honoraria from, and sits on advisory boards of, Novartis, BMS and MSD. The other authors declare no competing interests.